Every article, presentation, spotlight, and news item we've tagged to Women's Health.
Discover how adaptogenic herbs and alkaline nutrition can transform your midlife experience. Dr. Anna Cabeca's functional approach helps women navigate hormonal shifts with energy, clarity, and confidence.
Join Dr. Anna Cabeca, founder of The Girlfriend Doctor, for an empowering session on reclaiming vitality during menopause. Discover how hormonal optimization can transform your mood, energy, and overall well-being during midlife transitions. Dr. Cabeca will share evidence-based strategies for balancing hormones naturally, addressing common challenges like brain fog, weight gain, and emotional fluctuations. Learn practical biohacking techniques to not just survive menopause, but thrive through it with renewed confidence and vitality.
Naturopathic doctor Judy Seeger dismantles the myths and marketing hype surrounding women's longevity, delivering evidence-based strategies grounded in 30 years of clinical practice. This session cuts through the $77 billion wellness industry targeting women to reveal what actually works for healthy aging. Seeger addresses the critical gap in research—most studies are conducted on men—and provides women-specific guidance on protein needs, digestive health, movement patterns that boost brain health, stress management through grounding, and quality sleep. With practical tools like diagnostic belly checks and exercise snacks, she offers a strategic framework for reversing age-related decline without spending unnecessarily on supplements and quick fixes.
Bone density declines silently for decades before a fracture ever occurs. Radiation-free REMS technology offers a precise, accessible way to measure both bone density and microarchitecture, turning skeletal health from something abstract into something you can actively manage.
Gary Rhodes of Screen My Bones challenges the conventional approach to bone health with a personal mission born from his grandmother's osteoporosis diagnosis. Through hands-on demonstrations and balance testing, Rhodes reveals why bone density deserves attention decades before the typical age of diagnosis, introducing the concept of osteogenic loading and vibration training as tools for reconditioning skeletal strength. This interactive session reframes bone health not as inevitable decline to manage, but as a foundational pillar of longevity that can be actively improved through targeted intervention.
Winona, a telehealth menopause platform, launched a branded supplement line designed to address sleep disruption, digestive issues, bone and muscle decline, and nutritional gaps during perimenopause and menopause. The move reflects a clinical shift from symptom management alone toward supporting the physiological foundations that determine long-term health outcomes in women.
Breast cancer screening efficacy depends on individual risk stratification rather than one-size-fits-all mammography protocols. A risk-based framework allows clinicians to tailor screening modality, frequency, and timing to each person's specific risk profile, reducing unnecessary procedures while improving detection in high-risk populations.
Brain imaging reveals menopause involves significant neurological changes beyond reproductive shifts, with alterations in cerebral blood flow, neural connectivity, and metabolic function that persist into the post-menopausal years. Understanding these changes is essential for optimizing cognitive function and preventing age-related neurological decline in midlife women.
Menopause represents a critical inflection point for muscle health in women 55+, driven by estrogen decline and characterized by reduced muscle protein sensitivity—a shift that requires fundamentally different nutritional and training approaches than generic longevity advice provides. The convergence of hormonal change, anabolic resistance, and cumulative lifestyle factors creates a narrower margin for error precisely when intervention becomes most consequential for maintaining independence and metabolic reserve.
Cardiovascular health deteriorates significantly during perimenopause, with women in this transition phase showing twice the odds of poor cardiometabolic scores compared to premenopausal women. This critical window presents an opportunity for early intervention before postmenopausal decline solidifies, particularly through metabolic monitoring and dietary optimization.
Aging science built primarily on male biology has systematically misunderstood female physiology, leading to ineffective or harmful optimization strategies for women. A female-centered approach recognizes that women's hormonal cycles are rhythmic rather than erratic, and that sex-based differences in metabolism, hormone production, and social bonding represent distinct biological advantages requiring tailored intervention.
Women experiencing menopause report an average of nine concurrent symptoms, with 75% battling six or more simultaneously. This symptom clustering—particularly the co-occurrence of energy loss, weight gain, fatigue, and cognitive dysfunction—reflects systemic hormonal dysregulation rather than isolated complaints, with a median delay of one year before women access appropriate care.
Function Health positions comprehensive lab testing—160+ markers including metabolic and hormonal panels—as a foundation for preventive health monitoring, with emphasis on insulin, cortisol, thyroid, and leptin assessment to detect metabolic dysregulation earlier than standard screening. The model links biomarker tracking to lifestyle factors to inform individualized health optimization and support longitudinal monitoring.
Breast cancer screening efficacy depends less on tool availability than on individual risk stratification and informed decision-making aligned with personal values. Evidence supports screening protocols tailored to baseline risk, but implementation gaps between knowledge and clinical practice remain the primary barrier to optimized outcomes.
Continuous hormonal monitoring through wearable technology may address a fundamental gap in women's healthcare: the inadequacy of annual or biannual blood tests to capture hourly hormonal fluctuations. This shift from static snapshots to dynamic tracking could reveal patterns that isolated clinical measurements systematically miss, particularly during perimenopause and across reproductive transitions.
Early diagnosis of endometriosis and adenomyosis in adolescents and young women can prevent approximately 40% of disease progression and lesion formation. This finding reframes these conditions from inevitable gynecological problems to preventable or significantly modifiable disease states with major implications for fertility, reproductive lifespan, and systemic health outcomes.
Early menopause correlates with measurably reduced whole-brain metabolic activity, suggesting estrogen's role in maintaining cerebral energy production extends beyond reproductive function. This finding connects reproductive aging to neurological reserve and cognitive longevity.
Post-menopausal women show measurable reductions in gray matter volume within memory and emotion-regulating brain regions, correlating with increased anxiety, depression, and sleep disruption. This structural shift represents a neuroendocrine transition point with downstream implications for cognitive resilience and cardiometabolic risk in aging.
A seven-day pilot study of 40 women found that Basis supplementation correlated with self-reported reductions of 50% or more in hot flashes, bloating, and sleep disruption, alongside a statistically significant shift in estradiol-to-estrone ratio favoring estradiol dominance. The mechanism appears linked to NAD+ metabolism and estrogen balance during the menopausal transition.
Osteocalcin, a bone-derived hormone, increases compensatorily following ovarian hormone loss and protects neurological function in postmenopausal models. This identifies a previously unrecognized endocrine mechanism that mitigates neurodegeneration during estrogen deficiency, with implications for understanding neuroprotection across the lifespan.
Cyclana Bio has initiated a 500-patient observational study in the UK to identify molecular drivers of endometriosis through tissue analysis and 3D modeling. The research aims to clarify whether the condition requires a single therapeutic target or patient-stratified approaches, with implications for drug development in a disease affecting 1 in 10 women.
A microfluidics device enables recovery of immature oocytes from ovarian tissue, expanding the pool of viable eggs available for fertility preservation and IVF. This technology addresses a critical bottleneck in reproductive medicine by recovering oocytes that conventional methods miss, with direct implications for fertility outcomes across age groups.
Ursodeoxycholic acid (UDCA), a clinically available compound, restores mitochondrial quality in aged oocytes by upregulating EGR1, a transcription factor that coordinates cellular cleanup mechanisms. This identifies a tractable molecular pathway for addressing reproductive aging at its regulatory source rather than at the level of downstream dysfunction.
An analysis of over 800,000 Danish women found no association between menopausal hormone therapy and increased all-cause mortality over 7-21 years of follow-up. This challenges the prevailing safety concerns that emerged from earlier studies and suggests the risk-benefit calculation for hormone therapy in perimenopausal women warrants reassessment based on individual clinical context.
Deep learning analysis of histological and transcriptomic data from over 300 female donors reveals that reproductive organs age asynchronously rather than in lockstep, with menopause functioning as a critical inflection point detectable in circulating protein signatures. This challenges the assumption of synchronized aging across organ systems and identifies tissue-specific vulnerability windows relevant to longevity and disease prevention.
Colorectal cancer is uniquely interceptable through early screening before malignancy develops, making colonoscopy a critical preventive tool. Personalized screening strategies enable individuals to reduce cancer incidence and mortality through proactive detection and removal of precancerous lesions.
Antiosteoporotic medications initiated immediately after fracture do not impair healing despite clinical concerns, and their early use reduces refracture risk in older adults. This addresses a persistent treatment hesitation that may delay protection against secondary fractures in a vulnerable population.
Bisphosphonates do not impair fracture healing rate or timeline in osteoporotic patients, while teriparatide may accelerate union without delaying recovery. This systematic review clarifies medication safety during the critical window when skeletal integrity is compromised, directly informing treatment decisions for aging populations at high fracture risk.
The LE8 score—a composite measure of eight cardiovascular and lifestyle factors—independently predicts cancer risk across aging populations. This relationship suggests that modifiable health behaviors affecting circulation, metabolic function, and systemic resilience substantially influence cancer development trajectories.
